PMGC Holdings Inc ELAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update
-
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy
-
NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs
-
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
-
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
-
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
-
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss
-
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
Trading Information
- Previous Close Price
- $2.66
- Day Range
- $2.71–2.76
- 52-Week Range
- $2.59–1,537.32
- Bid/Ask
- $2.65 / $2.91
- Shares Outstanding
- 809,579.00
- Market Cap
- $2.19M
- Volume/Avg
- 1,368 / 46,681
Key Statistics
- Price/Earnings (Normalized)
- 0.00
- Price/Sales
- 0.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 34
- Website
- https://www.pmgcholdings.com
Valuation
|
Metric
|
ELAB
|
|---|---|
Price/Earnings (Normalized) | 0.00 |
Price/Book Value | 0.10 |
Price/Sales | 0.00 |
Price/Cash Flow | — |
Price/Earnings
ELAB
Financial Strength
|
Metric
|
ELAB
|
|---|---|
Quick Ratio | 1.27 |
Current Ratio | 1.36 |
Interest Coverage | −9.54 |
Quick Ratio
ELAB
Profitability
|
Metric
|
ELAB
|
|---|---|
Return on Assets (Normalized) | −67.89% |
Return on Equity (Normalized) | −123.80% |
Return on Invested Capital (Normalized) | −74.20% |
Return on Assets
ELAB
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|qwjK%Y | LOCK|%@nsr | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|W$QtBXR | LOCK|McjS | $83B | |||
| Moderna Inc
MRNA
| LOCK|<#mj<c | LOCK|PD | $80B | |||
| argenx SE ADR
ARGX
| LOCK|&@fVxy? | LOCK|$T | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|nJc&@v | LOCK|Lq | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|S^hN^yW | LOCK|VRwh< | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|fSXjr?s | LOCK|s>!@ | $28B | |||
| Incyte Corp
INCY
| LOCK|%<Dj@& | LOCK|HNs | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|!k?CS@s | LOCK|@nd | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|>!n><&J | LOCK|>$ | $14B |
United States